In the meantime, the blog saw several big news last week and actually had several interviews related to these news. I will share some of them here but all information that I had was already included in the newsletter for those who have already subscribed.
Let's start with Elevance's announcement on its new C18 diacids known as octadecanedioic acid (ODDA) under the trademark Inherent(tm). The mid-chain length diacid has long been available in the market in limited quantities but Elevance's metathesis processing technology at its newly started 180 ktpa biorefinery in Gresik, Indonesia, now made it possible for the diacid to be largely commercially produced with the potential of significantly expanding its applications in several markets.
No comments:
Post a Comment